See also this year's filing and all EDGAR filings for this company.
PDF Report 0001358403_2017_BELLICUM_PHARMACEUTICALS_INC.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.10728447872107909, 'aggregate_val': 35463000, 'exp_sum': 32027000, 'exp_to_value': {'LiabilitiesCurrent': 15113000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 16914000}} |
Graph
Absolute values for 0001358403, BELLICUM PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 105,610,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 16,504,000 |
| 3 | remainder_Assets | 9,923,000 |
| 4 | LiabilitiesCurrent | 15,113,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 20,350,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,925,000 |
| 9 | ResearchAndDevelopmentExpense | 51,263,000 |
| 10 | remainder_Expenses | 580,000 |
| 11 | remainder_Revenues | 388,000 |
| 12 | remainder_NetIncome | -861,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 132,037,000 |
| 1 | Liabilities | 35,463,000 |
| 2 | Expenses | 68,768,000 |
| 3 | Revenues | 388,000 |
| 4 | StockholdersEquity | 96,574,000 |
| 5 | NetIncome | -69,241,000 |
| 6 | ComprehensiveNetIncome | -69,241,000 |
| 7 | BaseVar | 118,758,500 |
| 8 | EconomicCapitalRatio | 1.16 |
Edgar->Model Mapping
Feature Distribution
